|
|
meiosis i
|
GO:0007127 |
60 |
0.756
|
|
|
|
deoxyribose phosphate metabolic process
|
GO:0019692 |
9 |
0.519
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.349
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.158
|
|
|
|
dna replication independent nucleosome assembly
|
GO:0006336 |
1 |
0.157
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.153
|
|
|
|
negative regulation of nuclear division
|
GO:0051784 |
19 |
0.151
|
|
|
|
meiotic cell cycle process
|
GO:1903046 |
77 |
0.134
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.123
|
Human |
|
|
meiotic cell cycle
|
GO:0051321 |
122 |
0.122
|
|
|
|
chromosome organization involved in meiosis
|
GO:0070192 |
39 |
0.120
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.119
|
|
|
|
synapsis
|
GO:0007129 |
34 |
0.117
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.113
|
Human |
|
|
sphingolipid biosynthetic process
|
GO:0030148 |
26 |
0.103
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.098
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.097
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.085
|
|
|
|
dna templated transcription termination
|
GO:0006353 |
4 |
0.085
|
|
|
|
chromosome segregation
|
GO:0007059 |
48 |
0.078
|
|
|
|
regulation of sphingolipid biosynthetic process
|
GO:0090153 |
1 |
0.071
|
|
|
|
spindle assembly involved in female meiosis i
|
GO:0007057 |
2 |
0.066
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.065
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.064
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.063
|
|
|
|
deoxyribonucleotide biosynthetic process
|
GO:0009263 |
6 |
0.063
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.063
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.056
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.055
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.051
|
|
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.050
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.049
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.049
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.047
|
|
|
|
cellular hyperosmotic salinity response
|
GO:0071475 |
0 |
0.046
|
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.046
|
|
|
|
female meiotic division
|
GO:0007143 |
21 |
0.045
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.044
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.043
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.043
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.043
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.042
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.042
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.039
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.038
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.037
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.037
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.036
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.036
|
|
|
|
female meiosis i
|
GO:0007144 |
7 |
0.035
|
|
|
|
positive regulation of glycogen catabolic process
|
GO:0045819 |
2 |
0.035
|
|
|
|
negative regulation of phagocytosis
|
GO:0050765 |
4 |
0.034
|
|
|
|
cilium morphogenesis
|
GO:0060271 |
102 |
0.031
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.031
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.031
|
|
|
|
myeloid cell homeostasis
|
GO:0002262 |
114 |
0.030
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.030
|
|
|
|
cilium assembly
|
GO:0042384 |
81 |
0.030
|
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.029
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.029
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.029
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.029
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.028
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.028
|
|
|
|
membrane lipid biosynthetic process
|
GO:0046467 |
32 |
0.027
|
|
|
|
spindle assembly involved in meiosis
|
GO:0090306 |
4 |
0.027
|
|
|
|
mrna catabolic process
|
GO:0006402 |
22 |
0.027
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.026
|
|
|
|
regulation of proteolysis involved in cellular protein catabolic process
|
GO:1903050 |
56 |
0.026
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.025
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
106 |
0.025
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.025
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.024
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.024
|
|
|
|
negative regulation of chromosome organization
|
GO:2001251 |
30 |
0.024
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
155 |
0.024
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.024
|
|
|
|
dna repair
|
GO:0006281 |
107 |
0.024
|
Human |
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.023
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.023
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.023
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.023
|
|
|
|
nuclear transcribed mrna catabolic process
|
GO:0000956 |
16 |
0.023
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.023
|
|
|
|
ceramide metabolic process
|
GO:0006672 |
31 |
0.022
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.022
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.022
|
|
|
|
mitochondrion organization
|
GO:0007005 |
134 |
0.022
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.022
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.022
|
|
|
|
nucleus localization
|
GO:0051647 |
20 |
0.021
|
|
|
|
deoxyribonucleotide metabolic process
|
GO:0009262 |
14 |
0.021
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.021
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
187 |
0.021
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.021
|
|
|
|
gene silencing by mirna
|
GO:0035195 |
10 |
0.020
|
|
|
|
negative regulation of multi organism process
|
GO:0043901 |
68 |
0.019
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.019
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.019
|
|
|
|
deoxyribose phosphate biosynthetic process
|
GO:0046385 |
3 |
0.019
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.019
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.019
|
|
|
|
mitotic cell cycle embryonic
|
GO:0045448 |
5 |
0.018
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.018
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.018
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.018
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.018
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.018
|
|
|
|
regulation of proteasomal protein catabolic process
|
GO:0061136 |
46 |
0.018
|
|
|
|
modification dependent macromolecule catabolic process
|
GO:0043632 |
133 |
0.018
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
28 |
0.018
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
76 |
0.018
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.017
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.017
|
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.017
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.017
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.017
|
|
|
|
mitochondrial transport
|
GO:0006839 |
36 |
0.017
|
|
|
|
positive regulation of transcription elongation from rna polymerase ii promoter
|
GO:0032968 |
2 |
0.017
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.017
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.017
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.016
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.016
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.016
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.016
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.016
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.016
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.016
|
|
|
|
regulation of cellular protein catabolic process
|
GO:1903362 |
61 |
0.016
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.016
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.016
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.016
|
|
|
|
response to muscle inactivity involved in regulation of muscle adaptation
|
GO:0014877 |
4 |
0.016
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.016
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.016
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.016
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.015
|
|
|
|
rna catabolic process
|
GO:0006401 |
29 |
0.015
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.015
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.015
|
|
|
|
posttranscriptional gene silencing by rna
|
GO:0035194 |
10 |
0.015
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.015
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.015
|
|
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.014
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.014
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.014
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.014
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.014
|
|
|
|
cognition
|
GO:0050890 |
149 |
0.014
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.014
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.014
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.014
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.013
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.013
|
|
|
|
regulation of multi organism process
|
GO:0043900 |
111 |
0.013
|
|
|
|
negative regulation of sequence specific dna binding transcription factor activity
|
GO:0043433 |
40 |
0.013
|
|
|
|
negative regulation of dna replication
|
GO:0008156 |
4 |
0.013
|
|
|
|
cell cycle comprising mitosis without cytokinesis
|
GO:0033301 |
1 |
0.013
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.013
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.012
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.012
|
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.012
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.012
|
|
|
|
negative regulation of lymphocyte differentiation
|
GO:0045620 |
32 |
0.012
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.012
|
|
|
|
regulation of protein catabolic process
|
GO:0042176 |
108 |
0.012
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.012
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.012
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.011
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.011
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.011
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.011
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.011
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.011
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.011
|
|
|
|
meiotic spindle organization
|
GO:0000212 |
9 |
0.011
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.011
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.011
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.011
|
|
|
|
blastocyst development
|
GO:0001824 |
80 |
0.011
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.011
|
|
|
|
protein acylation
|
GO:0043543 |
64 |
0.011
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.011
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.011
|
|
|
|
intra s dna damage checkpoint
|
GO:0031573 |
4 |
0.011
|
|
|
|
hatching
|
GO:0035188 |
4 |
0.011
|
|
|
|
pyrimidine deoxyribonucleotide biosynthetic process
|
GO:0009221 |
2 |
0.011
|
|
|
|
regulation of glycogen catabolic process
|
GO:0005981 |
2 |
0.010
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.010
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.010
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.010
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.010
|
|
|
|
positive regulation of viral genome replication
|
GO:0045070 |
2 |
0.010
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.010
|
|
|
|
dna conformation change
|
GO:0071103 |
37 |
0.010
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.010
|
|